Los bioestimuladores ofrecen mejoras progresivas durante varios meses
10.2450/2022.0172-22 20 HertzL.HuisjesR.Llaudet-PlanasE.Petkova-KirovaP.MakhroA.DanielczokJ
Disclaimer Articles on this website are meant for educational purposes only and are not intended to replace professional medical advice, diagnosis or treatment
If you experience severe nausea, vomiting, abdominal pain, or inability to tolerate food or fluids after resuming semaglutide, contact your healthcare provider immediately, as these symptoms could indicate either medication intolerance or a postoperative complication requiring evaluation
Moreover, inflammatory markers IL-1 and TNF- decreased by 30 %, demonstrating measurable anti-inflammatory action
A single centre experience of 3300 patients